Page last updated: 2024-08-21

chelidonine and Lung Neoplasms

chelidonine has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fan, XX; Gao, WN; Hussain, S; Jiang, ZB; Leung, EL; Li, W; Liu, L; Wang, WJ; Wang, YW; Wu, QB; Xie, YJ; Yao, XJ	1

Other Studies

1 other study(ies) available for chelidonine and Lung Neoplasms

Article	Year
Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway. Pharmacological research, 2020, Volume: 159 Topics: A549 Cells; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Benzophenanthridines; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Male; Mice, Nude; Mitochondria; Mutation; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays	2020

Article

Year

Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway.

Pharmacological research, 2020, Volume: 159

Topics: A549 Cells; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Benzophenanthridines; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Male; Mice, Nude; Mitochondria; Mutation; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays

2020